Sponsor pipeline

Hangzhou Converd Co., Ltd. clinical trial pipeline

Get alerts when Hangzhou Converd Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 2
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07006077 Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced… Advanced Pancreatic Cancer Recruiting 2026-02-27
Phase 1
NCT05914376 Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in… Advanced Solid Tumors Active, Not Recruiting 2026-02-27
Not applicable
NCT07185243 A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1… Advanced Solid Tumors Recruiting 2025-09-22

Disease areas by active trials

Pancreatic Cancer (1)

Get alerts when Hangzhou Converd Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free